Viking Therapeutics Inc. monthly returns
Viking Therapeutics Inc. has averaged 4.81% per month, positive in 43% of months. Month-by-month returns for Viking Therapeutics Inc. (VKTX) below, through October 16, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Viking Therapeutics Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -22.8% | |
| Sep 2026 | -0.5% | |
| Aug 2026 | +3.3% | |
| Jul 2026 | -18.6% | |
| Jun 2026 | +19.2% | |
| May 2026 | +5.0% | |
| Apr 2026 | -4.2% | |
| Mar 2026 | -3.8% | |
| Feb 2026 | +16.5% | |
| Jan 2026 | -17.5% | |
| Dec 2025 | -4.4% | |
| Nov 2025 | -3.3% | |
| Oct 2025 | +44.9% | |
| Sep 2025 | -2.8% | |
| Aug 2025 | -16.9% | |
| Jul 2025 | +22.9% | |
| Jun 2025 | -1.1% | |
| May 2025 | -7.2% | |
| Apr 2025 | +19.5% | |
| Mar 2025 | -16.3% | |
| Feb 2025 | -11.8% | |
| Jan 2025 | -18.6% | |
| Dec 2024 | -24.0% | |
| Nov 2024 | -27.0% | |
| Oct 2024 | +14.6% | |
| Sep 2024 | -1.3% | |
| Aug 2024 | +12.5% | |
| Jul 2024 | +7.5% | |
| Jun 2024 | -14.9% | |
| May 2024 | -21.8% | |
| Apr 2024 | -3.0% | |
| Mar 2024 | +6.4% | |
| Feb 2024 | +219.2% | |
| Jan 2024 | +29.7% | |
| Dec 2023 | +52.3% | |
| Nov 2023 | +24.6% | |
| Oct 2023 | -11.4% | |
| Sep 2023 | -19.8% | |
| Aug 2023 | -4.8% | |
| Jul 2023 | -10.5% | |
| Jun 2023 | -26.2% | |
| May 2023 | +3.1% | |
| Apr 2023 | +28.0% | |
| Mar 2023 | +51.2% | |
| Feb 2023 | +25.7% | |
| Jan 2023 | -6.8% | |
| Dec 2022 | +132.1% | |
| Nov 2022 | -1.2% | |
| Oct 2022 | +50.7% | |
| Sep 2022 | -14.5% | |
| Aug 2022 | +5.6% | |
| Jul 2022 | +4.2% | |
| Jun 2022 | +30.2% | |
| May 2022 | -6.7% | |
| Apr 2022 | -20.7% | |
| Mar 2022 | -10.4% | |
| Feb 2022 | -9.7% | |
| Jan 2022 | -19.3% | |
| Dec 2021 | -13.4% | |
| Nov 2021 | -8.8% | |
| Oct 2021 | -7.3% | |
| Sep 2021 | -5.0% | |
| Aug 2021 | +7.5% | |
| Jul 2021 | +2.7% | |
| Jun 2021 | +14.3% | |
| May 2021 | -18.0% | |
| Apr 2021 | +1.0% | |
| Mar 2021 | -6.2% | |
| Feb 2021 | -7.8% | |
| Jan 2021 | +29.8% | |
| Dec 2020 | -12.4% | |
| Nov 2020 | +14.2% | |
| Oct 2020 | -3.3% | |
| Sep 2020 | -13.0% | |
| Aug 2020 | -4.7% | |
| Jul 2020 | -2.6% | |
| Jun 2020 | +0.8% | |
| May 2020 | +24.1% | |
| Apr 2020 | +23.1% | |
| Mar 2020 | -20.9% | |
| Feb 2020 | -5.7% | |
| Jan 2020 | -21.7% | |
| Dec 2019 | +9.6% | |
| Nov 2019 | +13.1% | |
| Oct 2019 | -6.0% | |
| Sep 2019 | -1.0% | |
| Aug 2019 | -9.6% | |
| Jul 2019 | -7.3% | |
| Jun 2019 | +7.9% | |
| May 2019 | -1.8% | |
| Apr 2019 | -21.2% | |
| Mar 2019 | +18.2% | |
| Feb 2019 | +3.1% | |
| Jan 2019 | +6.7% | |
| Dec 2018 | -32.2% | |
| Nov 2018 | -17.0% | |
| Oct 2018 | -21.9% | |
| Sep 2018 | +33.3% | |
| Aug 2018 | +28.1% | |
| Jul 2018 | +7.5% | |
| Jun 2018 | -5.0% | |
| May 2018 | +142.5% | |
| Apr 2018 | -5.7% | |
| Mar 2018 | -30.2% | |
| Feb 2018 | +17.9% | |
| Jan 2018 | +30.8% | |
| Dec 2017 | +33.6% | |
| Nov 2017 | +27.7% | |
| Oct 2017 | +24.6% | |
| Sep 2017 | +83.7% | |
| Aug 2017 | -1.0% | |
| Jul 2017 | -2.8% | |
| Jun 2017 | -8.5% | |
| May 2017 | -15.7% | |
| Apr 2017 | -4.1% | |
| Mar 2017 | -4.6% | |
| Feb 2017 | +8.5% | |
| Jan 2017 | +18.5% | |
| Dec 2016 | +10.2% | |
| Nov 2016 | +0.9% |
Monthly total return (since Nov 2021)#
Viking Therapeutics Inc. returns by calendar month#
Every month of every year since 2016, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -22.79% — 10th of 11 Octobers since 2016 at the last close; the average October returned +6.1%.
| Month | −220%0+220% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | -0.7% | -6.8% | 45% | +30.8% 2018 | -39.0% 2016 | |
| Feb | +22.1% | +3.1% | 55% | +219.2% 2024 | -13.0% 2016 | |
| Mar | -3.5% | -6.2% | 27% | +51.2% 2023 | -30.2% 2018 | |
| Apr | +1.4% | -3.0% | 45% | +28.0% 2023 | -21.2% 2019 | |
| May | +9.0% | -4.8% | 36% | +142.5% 2018 | -21.8% 2024 | |
| Jun | +0.7% | -1.1% | 45% | +30.2% 2022 | -26.2% 2023 | |
| Jul | +1.3% | +2.7% | 55% | +22.9% 2025 | -18.6% 2026 | |
| Aug | +1.4% | -1.0% | 45% | +28.1% 2018 | -16.9% 2025 | |
| Sep | +5.8% | -1.3% | 27% | +83.7% 2017 | -19.8% 2023 | |
| Oct | +6.1% | -4.6% | 40% | +50.7% 2022 | -23.6% 2016 | |
| Nov | +2.3% | -0.1% | 50% | +27.7% 2017 | -27.0% 2024 | |
| Dec | +15.1% | +2.6% | 50% | +132.1% 2022 | -32.2% 2018 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from VKTX's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Viking Therapeutics Inc.'s average monthly return?
- Viking Therapeutics Inc. (VKTX) has averaged about 4.81% per month, positive in roughly 43% of months. The best month was Feb 2024 (+219.2%) and the worst was Jan 2016 (-39.0%).
